RemeGenix, Inc. was incorporated under the laws of the State of Delaware
in April 2006, commenced operations in our current line of business in early 2007, in the same month.
In 2009, the Company incorporated Cortica Neurosciences, and expects to rebrand the Company under
the Cortica name sometime in 2013, currently Cortica Neurosciences, Inc, also a Delaware corporation,
is a wholly owned subsidiary of RemeGenix, Inc.
Our principal executive offices are located at: | |
---|---|
4800 Montgomery Lane, Suite 800 Bethesda, Maryland 20814 Telephone: (518) 302-1515 Fax: (301) 476-0052 Contact Us |
View Larger Map |
Shares Authorized | Shares Outstanding | As of: | Affiliate | Non-Affiliate Float |
23,000,000 | 16,544,024 | 12/31/12 | 14,620,000 | 1,924,024 |
Chart | Last Price | Bid | Ask | Last Trade |
Coming Soon... | ||||
N/A | N/A | N/A | N/A | |
Volume | Market Cap | |||
N/A | est. 21M | |||
RemeGenix' Transfer Agent:
Globex Transfer, LLCRemeGenix Legal Counsel:
Peter Campitiello, Esq. (Partner)Shares Authorized | Shares Outstanding | As of: | Affiliate | Non-Affiliate Float |
23,000,000 | 16,544,024 | 12/31/12 | 14,620,000 | 1,924,024 |
Chart | Last Price | Bid | Ask | Last Trade |
Coming Soon... | ||||
N/A | N/A | N/A | N/A | |
Volume | Market Cap | |||
N/A | est. 21M | |||